Free Trial
LON:AREC

Arecor Therapeutics (AREC) Share Price, News & Analysis

Arecor Therapeutics logo
GBX 75
0.00 (0.00%)
(As of 10/31/2024 09:21 PM ET)

About Arecor Therapeutics Stock (LON:AREC)

Key Stats

Today's Range
74
75
50-Day Range
63.39
91
52-Week Range
62.55
199
Volume
100 shs
Average Volume
14,278 shs
Market Capitalization
£28.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It also offers Ogluo, a ready-to-use glucagon auto-injector pen that is used to treat hypoglycaemia in patients with diabetes; and specialty hospital care products. In addition, the company is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. It has a research collaboration with TRx Biosciences Limited for the formulation development of an oral glucagon-like peptide-1 (GLP-1) receptor agonist product. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.

Receive AREC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AREC Stock News Headlines

Rigged election?
Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late.
Arecor Therapeutics PLC Ordinary Shares AREC
See More Headlines

AREC Stock Analysis - Frequently Asked Questions

Arecor Therapeutics' stock was trading at GBX 182.50 on January 1st, 2024. Since then, AREC shares have decreased by 58.9% and is now trading at GBX 75.
View the best growth stocks for 2024 here
.

Shares of AREC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arecor Therapeutics investors own include Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Lowe's Companies (LOW) and SNDL (SNDL).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Coal
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
£-8,670,000.00
Net Margins
-176.89%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£4.90 million
Cash Flow
GBX 14.79 per share
Book Value
GBX 17 per share

Miscellaneous

Free Float
N/A
Market Cap
£28.32 million
Optionable
Not Optionable
Beta
-0.18
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:AREC) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners